Join the Weight Loss (Obesity / Overweight) group to help and get support from people like you.
Weight Loss (Obesity / Overweight) News (Page 15)
Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications
Drinking Lots of Water Really Is Good for You, Study Finds
FRIDAY, Nov. 29, 2024 – The collected evidence is in, and drinking about eight cups of water per day is, in fact, good for you. So says a University of California San Francisco team who crunched the...
Biden Seeks Coverage for GLP-1 RA Medications by Medicare, Medicaid
TUESDAY, Nov. 26, 2024 – The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) obesity medications like semaglutide (Wegovy)...
Zepbound Slashes Diabetes Risk in Obese Users
WEDNESDAY, Nov. 27, 2024 – The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the risk of diabetes...
Study Finds GLP-1 Meds, such as Ozempic, Wegovy, Can Also Help the Kidneys
TUESDAY, Nov. 26, 2024 – The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to...
Younger Age at Diabetes Diagnosis Tied to Higher Risk for Later Dementia
TUESDAY, Nov. 26, 2024 – Younger age at diagnosis of type 2 diabetes is significantly associated with a higher risk for subsequent dementia, according to a study published online Nov. 13 in PLOS...
Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds, such as Wegovy, Zepbound
TUESDAY, Nov. 26, 2024 – The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and...
Illinois Study Finds Steep Rise in Serious Complications of Pregnancy
MONDAY, Nov. 25, 2024 — Chronic health problems like high blood pressure, gestational diabetes and obesity have fueled a troubling rise in maternal health issues and birth complications in Illinois, a...
Taking a GLP-1 Medication? Here's Tips to Holiday Eating
SATURDAY, Nov. 23, 2024 – So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where...
U.S. Overweight, Obesity Rates Set to Continue Increasing to 2050
THURSDAY, Nov. 21, 2024 – Based on the current trajectory, overweight and obesity will continue increasing in the United States up to 2050, according to a study published online Nov. 14 in The...
Meds Like Ozempic Are Causing Folks to Waste More Food
FRIDAY, Nov. 22, 2024 – America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows. GLP-1s like Ozempic, Wegovy,...
'10 Americas:' Health Disparities Mean Life Expectancy Varies Across U.S.
FRIDAY, Nov. 22, 2024 – How long Americans can expect to live varies dramatically – and the gap continues to widen. A new report says health inequalities have, in essence, created 10 Americas....
AHA: Half of U.S. Adults Are Eligible for Treatment With Semaglutide
FRIDAY, Nov. 22, 2024 – More than half of all U.S. adults are eligible for semaglutide therapy, according to a research letter published online Nov. 18 in JAMA Cardiology to coincide with the ...
Vitamin D Supplements May Lower Blood Pressure in Seniors Who Are Overweight
WEDNESDAY, Nov. 20, 2024 – Among older individuals who are overweight, vitamin D supplementation coadministered with calcium reduces systolic and diastolic blood pressure (SBP and DBP), according to...
Weight-Loss Drug Zepbound May Lower Heart Failure Deaths
THURSDAY, Nov. 21, 2024 – A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand...
More Than Half of U.S. Adults Could Be Candidates for Ozempic
TUESDAY, Nov. 19, 2024 – More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as Ozempic for...
Further information
Related drug support groups
bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, tirzepatide, Adipex-P, Alli, orlistat, dulaglutide, garcinia cambogia, desvenlafaxine